Skip to content
value.today

Endotronix Inc.

Total raised
$108 M
3 rounds on record
Latest round
$69 M
Sep 2018
First round on record
Mar 2014
Today
Acquired
Acquired by Edwards Lifesciences Corporation

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of Endotronix Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Endotronix, IncEdwards Lifesciences Corporation2024—$800 M—Annual report

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Endotronix Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2018$69 MNo. 3$50 to $250 million

Endotronix Inc.: Raise no. 3, Sep 2018

Investors in this round

38 investors had bought by the notice of Dec 7, 2020: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$69 M of $91 M offered; $22 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harry Rowland · Executive Officer, Director
  • John Flavin · Executive Officer
  • Fouad Azzam · Director
  • Gerry Brunk · Director
  • James Hummer · Director
  • Jennifer McMahon · Director
  • Marc Goldberg · Director
  • Paul LaViolette · Director
  • Robert Zieserl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harry Rowland, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Dec 7, 2020. Read the notice at the SEC.

equitySEC
Jul 2016$37 MNo. 2$10 to $50 million

Endotronix Inc.: Raise no. 2, Jul 2016

Investors in this round

52 investors had bought by the notice of Feb 26, 2018: 52 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harry Rowland · Executive Officer, Director
  • Kent Elmer · Executive Officer
  • Gerry Brunk · Director
  • James Hummer · Director
  • Jennifer McMahon · Director
  • Marc Goldberg · Director
  • Paul LaViolette · Director
  • Robert Zieserl · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harry Rowland, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 26, 2018. Read the notice at the SEC.

equitySEC
Mar 2014$2 MNo. 1Under $2 million

Endotronix Inc.: Raise no. 1, Mar 2014

Investors in this round

4 investors had bought by the notice of Apr 29, 2014: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony A. Nunez · Executive Officer, Director
  • Harry Rowland · Executive Officer, Director
  • James J. Hummer · Director
  • Leslie A. Saxon · Director
  • Raymond S. Barrett, Jr. · Director
  • Sam R. Leno · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harry Rowland, Secretary and CEO. Source: SEC Form D, newest notice filed Apr 29, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Endotronix Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2020).

    SEC Form D · Dec 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2020

That is all the official record says: Endotronix Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Endotronix Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 52 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Endotronix Inc.
NameRoleNamed in
Harry RowlandExecutive officerDec 2020
John FlavinExecutive officerDec 2020
Kent ElmerExecutive officerFeb 2018
Anthony NunezExecutive officerJul 2016
Anthony A. NunezExecutive officerApr 2014
Fouad AzzamDirectorDec 2020
Gerry BrunkDirectorDec 2020
Harry RowlandDirectorDec 2020
James HummerDirectorDec 2020
Jennifer McMahonDirectorDec 2020
Marc GoldbergDirectorDec 2020
Paul LaVioletteDirectorDec 2020
Robert ZieserlDirectorDec 2020
Anthony A. NunezDirectorApr 2014
James J. HummerDirectorApr 2014
Leslie A. SaxonDirectorApr 2014
Raymond S. Barrett, Jr.DirectorApr 2014
Sam R. LenoDirectorApr 2014

Acquired (Jan 1, 2024). Acquired by Edwards Lifesciences Corporation.